PolyPeptide News Flash, #3, 2020
Business news
The PolyPeptide Group is working on projects with clients developing peptide-based therapies and vaccines to combat COVID-19.
As a Global Leader in Peptide Manufacturing and Development, the PolyPeptide Group has been actively engaged on projects with clients who are developing peptide-based therapies and vaccines to combat COVID-19. Also in this News Flash, learn more about PolyPeptide’s recent capacity expansion through investment and innovation.